About Maze Therapeutics
Maze Therapeutics is a biotechnology company focused on developing medicines that mimic the effects of rare, protective genetic variants to address unmet medical needs. Utilizing its Compass platform, the company identifies genetic variants associated with diseases and maps them to the biological pathways driving these conditions in specific patient populations.
Open positions (12)
Senior Project Manager, Clinical Operations
Director, Field Medical - West
Director, Clinical Business Operations
Senior Medical Director
Associate Director, CMC Project Management
Senior Director, Information Technology
Director, Field Medical - Central
Senior Director, Patient Advocacy
Director, Field Medical - East
Manager, Chemical Development
Senior Clinical Trial Specialist (PKU)
Director, Clinical Operations
Company details
Funding
Total raised
$646M
Last stage
Series A
Investors
Founders
Charles Homcy
Co-founder of Maze Therapeutics and served as its interim CEO at launch. A partner at Third Rock Ventures, he later became Chairman of the Board of Directors.
Mark Daly
Pioneer in the field of human genetics; co-director of the Program in Medical and Population Genetics at the Broad Institute and founding chief of the Analytic and Translational Genetics Unit at Massachusetts General Hospital.
Sekar Kathiresan
Scientific co-founder of Maze Therapeutics with expertise in cardiovascular genetics.
What happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.